On 24 April 2026 - 08:30-10:00 with:

Dr. Yury Tsybin (Spectroswiss)

 

Dr. Tsybin is the founder and CEO of Spectroswiss, a Swiss deep-tech company developing advanced hardware and software solutions for mass spectrometry (MS) data acquisition, processing, and analysis. He earned his Ph.D. in Ion Physics from Uppsala University (Sweden) and completed postdoctoral research with Prof. Alan G. Marshall at the National High Magnetic Field Laboratory (USA). Before founding Spectroswiss in 2014 as an EPFL spin-out, Dr. Tsybin was Assistant Professor of Physical and Bioanalytical Chemistry at EPFL, where he established the Biomolecular Mass Spectrometry Laboratory. His current research focuses on MS-based methods for structural analysis of biopharmaceuticals. Dr. Tsybin serves as President of the Swiss Group for Mass Spectrometry (SGMS), Associate Editor of JASMS, and is a recipient of the SGMS Award (2014) and the Curt Brunnée Award (2016).

 

Prof. Dr. Valérie Gabelica (University of Geneva)

Prof. Gabelica is specialized in nucleic acids native mass spectrometry. She obtained a PhD in Chemistry in 2002 at the University of Liège, Belgium. After a postdoc in Frankfurt as Humboldt fellow, she rejoined the Mass Spectrometry Laboratory in Liège where she obtained a permanent position as FNRS research associate in 2005. In 2013, she joined the Institut Européen de Chimie et Biologie (IECB, Bordeaux, France) with an appointment as research director of the French Institute for Health and Medical Research (INSERM) to study nucleic acids biophysics by mass spectrometry. She served as the director of the IECB from 2021 to 2023, obtained an ERC Consolidator grant in 2014, was awarded several research prizes, including the Heinrich Emanuel Merck Award for Analytical Sciences and Inserm research prize in 2022. In January 2024, she was appointed as Full Professor in Analytical Chemistry at the University of Geneva, Switzerland, in the School of Pharmaceutical Sciences. Her current research interests are mass spectrometry fundamentals (ionization, fragmentation, structures) and applications to native MS and oligonucleotides.